Invention Grant
- Patent Title: 4-pregenen-11β-17-21-triol-3,20-dione derivatives
- Patent Title (中): 4-前原-11β-17-21-三醇-3,20-二酮衍生物
-
Application No.: US14533847Application Date: 2014-11-05
-
Publication No.: US09433631B2Publication Date: 2016-09-06
- Inventor: Jeffrey L. Edelman , Alissar Nehme , Thomas C. Malone
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: A61K31/58
- IPC: A61K31/58 ; A61K31/573 ; C07J7/00 ; C07J17/00 ; C07J31/00 ; A61K31/56 ; A61K9/00 ; C07J5/00 ; A61K31/575
Abstract:
The present invention relates to novel 4-pregenen-11β-17-21-triol-3,20-dione derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals, as modulators of glucocorticoid or mineralocorticoid receptors. The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat disorders associated with glucocorticoid or mineralocorticoid receptor modulation.
Public/Granted literature
- US20150057258A1 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES Public/Granted day:2015-02-26
Information query
